IRIS
SIMILE, Maria Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.180
AS - Asia 3.286
EU - Europa 2.139
SA - Sud America 1.654
Continente sconosciuto - Info sul continente non disponibili 126
AF - Africa 102
OC - Oceania 12
Totale 13.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.965
BR - Brasile 1.476
SG - Singapore 1.320
CN - Cina 1.031
UA - Ucraina 564
IT - Italia 442
DE - Germania 264
VN - Vietnam 212
HK - Hong Kong 210
FR - Francia 207
SE - Svezia 159
GB - Regno Unito 146
FI - Finlandia 110
TR - Turchia 96
CA - Canada 93
IN - India 64
IQ - Iraq 53
BD - Bangladesh 50
AR - Argentina 49
CZ - Repubblica Ceca 49
MX - Messico 43
RU - Federazione Russa 43
BE - Belgio 33
EC - Ecuador 30
ZA - Sudafrica 29
ID - Indonesia 28
VE - Venezuela 28
UZ - Uzbekistan 27
MA - Marocco 25
PK - Pakistan 25
CO - Colombia 22
JP - Giappone 20
PL - Polonia 20
AT - Austria 19
ES - Italia 19
JO - Giordania 17
IR - Iran 16
KR - Corea 16
LT - Lituania 16
PY - Paraguay 15
CR - Costa Rica 14
CL - Cile 13
SA - Arabia Saudita 12
KE - Kenya 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
PA - Panama 10
SV - El Salvador 10
AZ - Azerbaigian 9
GT - Guatemala 9
HN - Honduras 9
NL - Olanda 8
NP - Nepal 8
PE - Perù 8
EU - Europa 7
IL - Israele 7
JM - Giamaica 7
MY - Malesia 7
NI - Nicaragua 7
OM - Oman 7
RO - Romania 7
TN - Tunisia 7
BO - Bolivia 6
PH - Filippine 6
SN - Senegal 6
UY - Uruguay 6
BG - Bulgaria 5
EG - Egitto 5
KZ - Kazakistan 5
PR - Porto Rico 5
AM - Armenia 4
CH - Svizzera 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
EE - Estonia 4
NG - Nigeria 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
QA - Qatar 3
RS - Serbia 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
CG - Congo 2
ET - Etiopia 2
IE - Irlanda 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
Totale 13.368
Salva come PNG Salva come JPEG
Città #
Dallas 1.470
Singapore 731
Chandler 674
San Jose 454
Ashburn 356
Jacksonville 336
Council Bluffs 225
Beijing 213
Hong Kong 208
Princeton 179
Santa Clara 173
Nanjing 137
Columbus 125
Dearborn 123
Sassari 117
Ann Arbor 99
São Paulo 98
Wilmington 96
Lauterbourg 88
Los Angeles 81
Ho Chi Minh City 76
Nanchang 69
Rio de Janeiro 69
Shanghai 68
Boardman 62
Milan 57
Hanoi 51
Izmir 51
Brno 43
Changsha 42
Woodbridge 42
New York 41
Shenyang 38
Tianjin 37
Belo Horizonte 33
Brussels 33
Munich 31
Toronto 31
The Dalles 30
Brasília 28
Hebei 28
Jinan 26
Orem 26
Baghdad 25
London 25
Mountain View 25
Tashkent 25
Jiaxing 24
Zhengzhou 24
Porto Alegre 22
Miano 21
Chennai 20
Ningbo 20
Rome 20
Tokyo 20
Helsinki 19
Nuremberg 19
Campinas 18
Hangzhou 18
Warsaw 18
Amman 17
Brooklyn 17
Guarulhos 17
San Francisco 17
Boston 16
Goiânia 16
Atlanta 15
Augusta 15
Denver 15
Johannesburg 15
Montreal 15
Seoul 15
Buffalo 14
Frankfurt am Main 14
Leawood 14
Stockholm 14
Chicago 13
San Mateo 13
Ardabil 12
Casablanca 12
Falls Church 12
Norwalk 12
Osasco 12
Salvador 12
São Bernardo do Campo 12
Andover 11
Aracaju 11
Guangzhou 11
Guayaquil 11
Mexico City 11
Nairobi 11
Phoenix 11
Praia Grande 11
Taizhou 11
Curitiba 10
Dhaka 10
Houston 10
Istanbul 10
Kunming 10
Lanzhou 10
Totale 7.873
Salva come PNG Salva come JPEG
Nome #
Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury 254
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 229
1-5-formyltetrahydrofolate and 1-5-methyltetrahydrofolate rescue in L-1210 leukemia treated with high methotrexate doses 229
5' Methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon tetrachloride intoxication 221
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 209
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 204
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 200
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 199
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 197
Chemoprevention of hepatocarcinogenesis: S.adenosyl-L-methionine 190
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 188
Altered methionine metabolism and global DNA methylation in liver cancer: Relationship with genomic instability and prognosis 187
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 186
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 181
Amplification of c-myc oncogene in preneoplastic e neoplastic lesions induced in rat liver by the resistant hepatocyte protocol 173
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 172
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 171
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 171
Experimental models to define the genetic predisposition to liver cancer 171
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 169
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 168
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 167
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 167
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 167
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 166
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 165
MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes 164
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 163
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 161
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 161
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 160
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 160
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 157
Implication of Bcl 2 family genes in basal and D amphetamine induced apoptosis in preneoplastic and neoplastic rat liver lesions 156
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 155
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 154
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 154
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans 153
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/b-catenin pathway and progression of early lesions in the rat 150
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 150
Alterations of methionine metabolism as potential targets for the prevention and therapy of hepatocellular carcinoma 150
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 144
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 144
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 142
Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats 142
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 141
Identification of genetic loci controlling hepatocarcinogenesis on rat chromosomes 7 and 10 140
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 139
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 139
THE BN RAT STRAIN CARRIES DOMINANT HEPATOCARCINOGEN RESISTANCE LOCI 138
Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma 138
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 137
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 134
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 134
Simile, M.M., Pagnan, G., De Miglio, M.R., Muroni, M.R., Asara, G., Frau, M., Seddaiu M.A., Feo, F., Ponzoni, M., and Pascale, R.M 133
Induction by human interferon and murine h-2l(d) gene of the surface expression of endogenous hla class-I free heavy-chains in hct human colon-carcinoma cells, deficient in Beta-2-microglobulin 130
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 129
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma 128
Modulation by MHC class I antigens of the biology of melanoma cells. Non-immunological mechanisms. 126
Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats 126
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 124
The warburg effect 97 years after its discovery 122
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 121
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats 121
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 120
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 116
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 116
New putative prognostic markers and therapeutic targets for the molecular approach to treatment of hepatocellular carcinoma 116
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 115
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC 110
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 108
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 107
Mapping a sex-hormone sensitive gene determining female resistance to liver carcinogenesis in a congenic F344 BN-Hcs4 rat. 107
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 105
Focal loss of long non-coding RNA-PRAL, as determinant of cell function and phenotype of hepatocellular carcinoma 105
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 104
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 104
Transferrin and transferrin receptor gene expression in benign and malignant rat liver lesions. 103
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent 102
Role of perturbation of methionine metabolism and global DNA methylation in the generation of genomic instability in transgenic mouse models of liver cancer 100
Polygenic predisposition to hepatocellular carcinoma. 99
Genetic alterations in liver carcinogenesis: implication for new preventive therapeutic strategies 98
Re-expression of the major histocompatibility complex (MHC) class I antigen H-2K b by M1 (B16-F10) murine melanoma cells 98
Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy. 96
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 96
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis 94
Identification and characterization of a cDNA clone for a gene overexpressed in preneoplastic e neoplastic lesions in rat liver 94
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. 45° Annual Meeting of the European Association for the Study of the Liver (EASL) Aprile 14-18, 2010 93
Hepatocellular carcinoma as a complex polygenic disease. Interpretative analysis of recent developments on genetic predisposition 93
eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma 91
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation 89
Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat 89
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 87
Sequential analysis of epigenetic and genetic events during rat liver carcinogenesis. 83
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma 74
Genetic Predisposition to Hepatocellular Carcinoma 66
Totale 13.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022424 0 0 0 7 12 22 29 25 46 29 53 201
2022/20231.160 126 109 25 213 99 194 0 128 185 7 46 28
2023/2024290 58 20 6 10 38 4 0 23 0 3 39 89
2024/20253.076 21 26 158 95 152 99 246 534 1.004 492 163 86
2025/20264.535 217 1.134 684 523 401 267 604 127 179 234 127 38
2026/20271.356 136 301 369 550 0 0 0 0 0 0 0 0
Totale 13.499